FGF23 and chronic kidney disease: Paradoxically, the expected beneficial effect of the compensatory increase in circulating levels of FGF23 to maintain phosphorus homeostasis contrasts with multiple observational data correlating elevated serum levels of FGF23 with cardiovascular and all-cause mortality in patients with CKD, especially those on dialysis.